<DOC>
	<DOCNO>NCT00781937</DOCNO>
	<brief_summary>This trial conduct North America . The aim clinical trial evaluate potential liraglutide maintain long term weight loss obese non-diabetic subject , well overweight subject medical problem hypertension ( high blood pressure ) dyslipidaemia ( abnormal amount lipid blood ) . Trial follow trial period : A 12-week run-in period ( week -12 week 0 ) follow 56-week main trial period ( week 0-56 ) 12-week follow-up period ( week 56-68 ) .</brief_summary>
	<brief_title>Comparison Liraglutide Versus Placebo Weight Loss Maintenance Obese Subjects : SCALE - Maintenance</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Body Mass Index ( BMI ) either 30 kg/m^2 BMI le 30 kg/m^2 27 kg/m^2 presence comorbidities Stable body weight previous 3 month ( less 5 kg selfreported weight change ) Previously undergone dietary weight loss able maintain reduce weight Diagnosis type 1 type 2 diabetes Previous treatment GLP1 ( glucagonlike peptide1 ) receptor agonist ( include liraglutide exenatide ) , within last 3 month Visit 1 thryoid stimulate hormone ( TSH ) outside range 0.46.0 mIU/L History chronic pancreatitis idiopathic acute pancreatitis Obesity induce endocrinologic disorder ( e.g. , Cushing Syndrome ) Current history treatment medication may cause significant weight gain least 3 month trial Current participation organize diet reduction program ( within last 3 month ) Currently use use within three month trial : pramlintide , sibutramine , orlistat , zonisamide , topiramate , phenteremine , metformin Previous surgical treatment obesity ( exclude liposuction perform one year trial entry ) History major depressive disorder PHQ9 ( Patient Health Questionnaire9 ) score 15 within last 2 year history severe psychiatric disorder diagnosis eat disorder Subjects lifetime history suicide attempt history suicidal behavior within past month entry trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>